Navigation Links
Atherotech Unveils New Cardiometabolic Test Panels
Date:3/30/2009

Heart disease and diabetes markers to complement VAP advanced cholesterol profile

ORLANDO, Fla. and BIRMINGHAM, Ala., March 30 /PRNewswire/ -- Atherotech, Inc., developer of the VAP Cholesterol Test, has announced the addition of new cardiovascular and metabolic testing panels at ACC.09, the American College of Cardiology (ACC) 58th Annual Scientific Session Exposition. Atherotech is adding more than a dozen new tests, including C-Reactive Protein (hsCRP), ApoE genotype, and NT-proBNP, for assessment of patients at intermediate to high risk of cardiometabolic diseases. The company is also adding advanced and follow-up cardiovascular disease (CVD) risk profiles.

"We're maximizing the value of our core VAP technology with additional cardiometabolic tests," said Atherotech President Michael Mullen. "This provides physicians and cardiology practices with a single source for the VAP Cholesterol Test plus the new test panels. You get the complete cardiovascular and metabolic view."

Atherotech representatives will be available to discuss the VAP Cholesterol Test and new test panels in booth #1263, and blood draws will be provided to qualified attendees during exhibit hours March 29-31. Because LDL is directly measured, fasting is not required. Test results will be returned via mail after the conference.

The VAP Test, which recently added apoAI (and the apoB/apoAI ratio) to its panel, uses advanced lipid profile testing in the identification of individuals at increased risk of heart disease. The new test panels enable Atherotech to increase its scientific and diagnostic capabilities by offering much more complete cardiometabolic testing.

Steven Margolis, M.D., FAAFP, DABCL, a board-certified lipidologist who currently uses the VAP Test for advanced lipid testing of patients in his Sterling Heights, Mich., practice, says the new testing panels add significant benefits for practices
'/>"/>

SOURCE Atherotech, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Atherotech to Exhibit the VAP(R) Cholesterol Test at ACC.09 in Orlando
2. Atherotech Announces Addition of ApoAI Heart Disease, Diabetes Risk Marker to VAP(R) Test
3. Atherotech to Exhibit VAP(R) Cholesterol Test at American Heart Association Scientific Sessions 2008
4. VAP(R) Cholesterol Test From Atherotech Covers an Additional 9 Million of Florida Insured
5. Atherotech to Exhibit the VAP Test at Internal Medicine 2008
6. Atherotech VAP Cholesterol Test Meets Updated ADA, ACC Measurement and Treatment Guidelines for High Risk Patients
7. Atherotech to Exhibit the VAP Test (R) at ACC 2008 Meeting in Chicago
8. VAP Cholesterol Test From Atherotech Covers 90 Percent of Arizona Insured
9. Atherotech Says Detailed Cholesterol Test Can Help Doctors and Patients Choose Best Therapy
10. DNA 11 Unveils Modern-Day Family Portraits at The Museum of Science and Industry's Smart Home: Green + WIRED Exhibit
11. Pharma ChemOutsourcing Unveils 100 Pharma & Biotech Speaker Faculty for 2009 Conference September 14-16 in Long Branch, NJ
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... 27, 2014 Tris Pharma, a specialty pharmaceutical ... announced that it has been selected as an award ... 2014 Awards for Excellence competition in the ... panel of judges from SCORE (Counselors to America,s Small ... be honored at a gala event to be held ...
(Date:8/27/2014)... After the boom of the energy ... beverage craze is going to be the stress relief ... use Stress Relief energy pattern which can be applied ... a beverage, including minerals, herbs and liquids. Stress Relief ... power into rapid recovery and helping to adapt more ...
(Date:8/27/2014)... August 27, 2014 WriteResult, LLC – ... has once again shown superiority when it comes to ... completing the ePRO portion of their most recent study ... Japan-based pharma chose WriteResult’s digital writing platform to collect ... the first to complete drew data from a number ...
(Date:8/26/2014)... , Aug. 26, 2014  NeuroSigma, Inc., a ... to develop bioelectronic technologies, today announced that it has ... U.S. Securities and Exchange Commission relating to a proposed ... of shares to be offered and the price range ... Jefferies LLC will act as the book-running ...
Breaking Biology Technology:Tris Pharma Selected as an award winner in the New Jersey Business & Industry Association's 2014 Awards for Excellence 2Stress Relief: 1 Way to De-Stress Your Beverage Formula 2Stress Relief: 1 Way to De-Stress Your Beverage Formula 3Stress Relief: 1 Way to De-Stress Your Beverage Formula 4A Perfect Record: WriteResult Maintains a 100% On-Time ePRO Record with Latest Irritable Bowel (IBS) Study Data Lock 2
... Research Inc., (TSX:,ARI), a biotechnology company discovering and ... its financial and operational,results for the third quarter, ... of fiscal 2007 was one of preparation as ... into human clinical trials in,2008, while also building ...
... N.C., Oct. 12 Campbell Alliance, the leading,management ... today announced that Ben Bonifant, Vice President,of the ... at the Licensing Executive Society (LES) Annual Meeting. ... at the Vancouver Convention and,Exhibit Centre in Vancouver, ...
... 12 QuantiFERON(R)-TB Gold,In- Tube is Poised to ... for,Accurate & Effective Tuberculosis Screening October 12 ... controllers around the,country can now quickly and accurately ... Drug Administration (FDA) approval of,QuantiFERON(R)-TB Gold In-Tube (QFT(TM)). ...
Cached Biology Technology:ARIUS Announces Third Quarter Fiscal 2007 Financial Results 2ARIUS Announces Third Quarter Fiscal 2007 Financial Results 3ARIUS Announces Third Quarter Fiscal 2007 Financial Results 4ARIUS Announces Third Quarter Fiscal 2007 Financial Results 5ARIUS Announces Third Quarter Fiscal 2007 Financial Results 6ARIUS Announces Third Quarter Fiscal 2007 Financial Results 7ARIUS Announces Third Quarter Fiscal 2007 Financial Results 8ARIUS Announces Third Quarter Fiscal 2007 Financial Results 9ARIUS Announces Third Quarter Fiscal 2007 Financial Results 10ARIUS Announces Third Quarter Fiscal 2007 Financial Results 11ARIUS Announces Third Quarter Fiscal 2007 Financial Results 12ARIUS Announces Third Quarter Fiscal 2007 Financial Results 13ARIUS Announces Third Quarter Fiscal 2007 Financial Results 14ARIUS Announces Third Quarter Fiscal 2007 Financial Results 15Campbell Alliance Business Development Practice to Moderate Two Workshops at LES Annual Meeting in Vancouver 2Campbell Alliance Business Development Practice to Moderate Two Workshops at LES Annual Meeting in Vancouver 3Cellestis Receives FDA Approval for Blood Test for Detecting Tuberculosis 2Cellestis Receives FDA Approval for Blood Test for Detecting Tuberculosis 3
(Date:8/27/2014)... advocates, campaigns against trans-fats have largely succeeded in ... aim at sugar for its potential contributions to ... still wrangling over the best way to assuage ... article in Chemical & Engineering News ... Chemical Society. , In the article, Stephen Ritter, ...
(Date:8/27/2014)... factors thought to be associated with outcomes after ... age of the patient, mechanism of injury, nerve ... method, operation technique, and repair materials. However, despite ... peripheral nerve injuries, there is no agreement regarding ... the dose-effect relationship of the predictors has not ...
(Date:8/27/2014)... hours ago the Happy Camp Complex of fires had ... July complex had consumed 35,530 as of eight hours ... the Happy Camp Ranger District of the Klamath National ... August 11, 2014. All but three of those fires ... list of contained fires and their size at containment: ...
Breaking Biology News(10 mins):Happy Camp and July Fire Complexes in California 2
... a heart attack. But the damage to heart muscle is ... the most common cause of death in developed countries. ... body can,t do: mending broken hearts. Engineers and physicians at ... the growth and integration of stem cell-derived cardiac muscle cells. ...
... RIVERSIDE, Calif. Anthony Norman , a ... policy changes regarding people,s vitamin D daily intake ... to reducing the frequency of many diseases, including ... hypertension, cardiovascular disease, obesity and muscle weakness. ...
... German . , Those who have to fight ... physicists from different scientific fields have decided to cooperate with ... through heat treatment by means of magnetic nanoparticles on a ... to improve the success of the therapy. Within the scope ...
Cached Biology News:A strategy to fix a broken heart 2A strategy to fix a broken heart 3Biochemist proposes worldwide policy change to step up daily vitamin D intake 2Biochemist proposes worldwide policy change to step up daily vitamin D intake 3How many nanoparticles heat the tumor? 2How many nanoparticles heat the tumor? 3
Rabbit Serum New Zealand or California Origin...
... Customer Peptide Synthesis , Containing one Phospho-Amino Acid ... be returned to customer conjugation of peptide to KLH protein ... 102 days/each , Pre-immune bleed x1 /each ... , Test bleed (app. 5 ml) x1 /each ...
...
GeneRacer is an advanced RACE (rapid amplification of cDNA ends) technique that improves the efficiency of amplifying full-length 5' and 3' cDNA ends. With the GeneRacer Kit you can:...
Biology Products: